메뉴 건너뛰기




Volumn 8, Issue 9, 2012, Pages 482-483

Stroke: Expanded indications for stroke thrombolysisĝ€"what next?

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTITHROMBOCYTIC AGENT; DESMOTEPLASE; PLACEBO; TENECTEPLASE;

EID: 84866087039     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.151     Document Type: Short Survey
Times cited : (6)

References (10)
  • 2
    • 84861056179 scopus 로고    scopus 로고
    • Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack
    • Davis, S. M. & Donnan, G. A. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N. Engl. J. Med. 366, 1914-1922 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , pp. 1914-1922
    • Davis, S.M.1    Donnan, G.A.2
  • 4
    • 84862625338 scopus 로고    scopus 로고
    • A randomised controlled trial
    • IST-3 Collaborative Group. The Benefits And Harms Of Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator Within 6 H Of Acute Ischaemic Stroke (the Third International Stroke Trial [IST 3])
    • IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST 3]): A randomised controlled trial. Lancet 379, 2352-2363 (2012).
    • (2012) Lancet , vol.379 , pp. 2352-2363
  • 5
    • 84858274819 scopus 로고    scopus 로고
    • Statistical analysis plan for the third international stroke trial (IST 3); part of a 'thread' of reports of the trial
    • Sandercock, P., Lindley, R., Wardlaw, J., Whiteley, W. & Murray, G. Statistical analysis plan for the third international stroke trial (IST 3); part of a 'thread' of reports of the trial. Int. J. Stroke 7, 186-187 (2012).
    • (2012) Int. J. Stroke , vol.7 , pp. 186-187
    • Sandercock, P.1    Lindley, R.2    Wardlaw, J.3    Whiteley, W.4    Murray, G.5
  • 6
    • 84862629039 scopus 로고    scopus 로고
    • Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis
    • Wardlaw, J. M. et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis. Lancet 379, 2364-2372 (2012).
    • (2012) Lancet , vol.379 , pp. 2364-2372
    • Wardlaw, J.M.1
  • 7
    • 84862691077 scopus 로고    scopus 로고
    • Plasminogen activation and thrombolysis for ischemic stroke
    • Medcalf, R. L. & Davis, S. M. Plasminogen activation and thrombolysis for ischemic stroke. Int. J. Stroke 7, 419-425 (2012).
    • (2012) Int. J. Stroke , vol.7 , Issue.419-425
    • Medcalf, R.L.1    Davis, S.M.2
  • 8
    • 84155184488 scopus 로고    scopus 로고
    • A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)
    • Ma, H. et al. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int. J. Stroke 7, 74-80 (2012).
    • (2012) Int. J. Stroke , vol.7 , Issue.74-80
    • Ma, H.1
  • 9
    • 84858685702 scopus 로고    scopus 로고
    • A randomized trial of tenecteplase versus alteplase for acute ischemic stroke
    • Parsons, M. et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N. Engl. J. Med. 366, 1099-1107 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , Issue.1099-1107
    • Parsons, M.1
  • 10
    • 84861580849 scopus 로고    scopus 로고
    • Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase
    • Fiebach, J. B. et al. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase. Stroke 43, 1561-1566 (2012).
    • (2012) Stroke , vol.43 , pp. 1561-1566
    • Fiebach, J.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.